France Wearables in Pharma & Biotech Market (2026-2031)
The France Wearables in Pharma & Biotech Market was valued at $240.7 Million in 2026 and projected to reach to $672.7 Million by 2031, representing a compound annual growth rate of 22.8%. France's wearables in pharma and biotech market is poised for sustained expansion through 2031, driven by increasing healthcare digitalization, growing adoption of remote patient monitoring, and strong government support for medical technology innovation.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
France Wearables in Pharma & Biotech Market Trends and Insights
- This represents a compound annual growth rate of 22.8%, significantly outpacing global trends and reflecting France's strong position in digital health innovation and regulatory support for medical device adoption.
- France's healthcare infrastructure, combined with increasing investment in remote patient monitoring and personalized medicine, is driving accelerated adoption of wearable technologies across pharmaceutical and biotech applications. The French market benefits from a mature healthcare ecosystem and government initiatives promoting digital transformation in clinical settings.
- France's pharmaceutical and biotech sectors are leveraging wearables for real-world evidence generation, clinical trials optimization, and chronic disease management.
- By 2031, France is expected to consolidate its leadership in European wearables adoption, with expanding applications in cardiology, neurology, and metabolic disorders driving sustained market growth..
Key Market Statistics
- CAGR (2026-2031) 22.8% CAGR
- Market Size, 2026 ~USD 240.7 Million
- Forecast, 2031 ~USD 672.7 Million
- Country France
France Wearables in Pharma & Biotech Market Overview
Exceptional Growth Trajectory :
France's wearables in pharma and biotech market is expanding at 22.8% CAGR, significantly outpacing the global rate of 20.2%, demonstrating France's accelerated adoption of digital health technologies and medical device innovation.
Substantial Market Valuation :
The French market is valued at USD 240.7 million in 2026 and is projected to nearly triple to USD 672.7 million by 2031, reflecting strong investment in healthcare digitalization and regulatory support for wearable medical devices.
Regulatory Leadership :
France benefits from robust EU regulatory frameworks and national healthcare policies that actively support the adoption of wearable technologies in pharmaceutical and biotech applications, creating a favorable market environment.
Digital Health Innovation Hub :
France's strong position in digital health innovation, combined with advanced healthcare infrastructure and R&D capabilities, positions the country as a key market for wearable pharma and biotech solutions in Europe.
France Wearables in Pharma & Biotech Market Dynamics
- The market's 22.8% CAGR reflects France's commitment to integrating wearable devices into clinical workflows and pharmaceutical development processes. Key growth drivers include rising chronic disease prevalence, demand for personalized medicine, and investment in digital health infrastructure.
- French pharmaceutical companies and biotech firms are increasingly leveraging wearables for clinical trials, patient monitoring, and drug efficacy assessment.
- This convergence of regulatory support, technological advancement, and healthcare modernization positions France as a leading European market for wearable pharma and biotech solutions..
Related Ecosystem
Healthcare It
- Computed Tomography (CT)
- Machine Learning
- Magnetic Resonance Imaging (MRI)
- Natural Language Processing (NLP)
- Predictive Analytics
- CERNER CORPORATION
- PHILIPS HEALTHCARE
- Oracle Corporation
- GE HealthCare Technologies Inc.
- Siemens healthineers
Key Takeaways
- France's wearables in pharma & biotech market is valued at USD 240.7 million in 2026 and will grow to USD 672.7 million by 2031, representing a 22.8% CAGR.
- France's growth rate of 22.8% CAGR exceeds the global average, positioning France as a high-growth market within Europe for wearable healthcare technologies.
- France's mature healthcare infrastructure and government digital health initiatives are accelerating adoption of wearables for clinical trials, remote monitoring, and real-world evidence.
- By 2031, France is expected to lead European adoption of wearables in pharmaceutical and biotech applications, particularly in cardiology, neurology, and chronic disease management.
Wearables in Pharma & Biotech Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | MENTAL HEALTH & BEHAVIORAL HEALTH (Therapeutic Area) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 20.2% from 2026 to 2031 |
| Largest Segment | PHARMACEUTICAL & BIOTECH COMPANIES (End User) |
| Market Size Base Year (Billions) | ~USD 3.97 (2026) |
| Revenue Forecast (Billions) | ~USD 9.97 (2031) |
| Segments Covered | Product, Therapeutic Area, Type, Application, End User |
France Wearables in Pharma & Biotech Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product
- Continuous Glucose Monitors
- Fitness Bands
- Other Products
- Patches
- Smart Rings
- Smartwatches
- Wearable Injectors
By Therapeutic Area
- Cardiovascular
- Diabetes
- Lifestyle & Wellness Improvement
- Mental Health & Behavioral Health
- Musculoskeletal Disorders/Pain Management
- Neurology
- Oncology
- Other Diseases
- Respiratory Disorders
- Women’S Health & Reproductive Health
By Type
- Atherosclerotic Cardiovascular Diseases/Secondary Prevention
- Atrial Fibrillation/Stroke Prevention
- Brain Tumor
- Breast Cancer
- Colorectal Cancer
- Heart Failure
- Hematologic Malignancies
- Hypertension
- Leukemia
- Lung Cancer
- Lymphoma
- Multiple Myeloma
- Other Hematologic Malignancies
- Other Solid Tumors
- Phase Ii
- Phase Iii
- Phase Iv
- Prostate Cancer
- Pulmonary Hypertension
- Solid Tumors
- Structural Heart Diseases/Interventional Cardiology
By Application
- Chronic Disease Monitoring
- Clinical Trials
- Drug Discovery
- Medication Adherence & Behavioral Support
- Personalized & Preventive Digital Therapeutics
By End User
- Contract Research Organizations
- Healthcare Providers & Clinicians
- Other End Users
- Pharmaceutical & Biotech Companies
FRANCE: WEARABLES IN PHARMA & BIOTECH MARKET, BY END USER, 2024–2031
| Segment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| CONTRACT RESEARCH ORGANIZATIONS | 54.4 | 66.3 | 81.2 | 99.9 | 123.4 | 153 | 190.3 | 237.2 | 23.9 |
| HEALTHCARE PROVIDERS & CLINICIANS | 17.6 | 21.1 | 25.4 | 30.7 | 37.2 | 45.3 | 55.3 | 67.8 | 21.7 |
| OTHER END USERS | 8.2 | 9.8 | 11.6 | 13.8 | 16.5 | 19.8 | 23.8 | 28.6 | 19.7 |
| PHARMACEUTICAL & BIOTECH COMPANIES | 84 | 101.2 | 122.6 | 149.2 | 182.3 | 223.5 | 275 | 339.1 | 22.6 |
| TOTAL | 164.2 | 198.3 | 240.7 | 293.6 | 359.5 | 441.6 | 544.4 | 672.7 | 22.8 |
Target Audience
- Pharmaceutical Companies : French and international pharma firms need France-specific market data to develop wearable-integrated drug delivery systems, clinical trial strategies, and patient monitoring solutions aligned with French healthcare regulations.
- Biotech Enterprises : Biotech innovators require detailed France market insights to identify opportunities for wearable-enabled diagnostics, personalized medicine platforms, and digital biomarkers in this high-growth European market.
- Medical Device Manufacturers : Device makers need France-focused market analysis to understand regulatory pathways, reimbursement mechanisms, and competitive positioning for wearable medical devices in the French healthcare system.
- Healthcare Investors & VCs : Investment firms targeting France's digital health sector require accurate market forecasts and growth metrics to evaluate funding opportunities in wearable pharma and biotech startups and established players.
- Healthcare Consultants & Strategists : Consulting firms advising clients on France market expansion need comprehensive, country-specific data on wearable adoption trends, market dynamics, and strategic opportunities in pharma and biotech sectors.
Key Companies in the France Wearables in Pharma & Biotech Market
| Company | HQ | Ownership | Strongest segments |
|---|
Reasons to Buy this Report
- Market-Specific Growth Intelligence : Gain detailed insights into France's 22.8% CAGR trajectory and understand the unique drivers accelerating wearable adoption in French pharma and biotech sectors compared to global benchmarks.
- Accurate Valuation & Forecasting : Access precise market sizing data for France (USD 240.7M in 2026, USD 672.7M in 2031) to inform investment decisions, business planning, and resource allocation strategies specific to the French market.
- Regulatory & Compliance Landscape : Understand France's regulatory environment and healthcare policies supporting wearable medical device adoption, enabling compliant market entry and product development strategies tailored to French requirements.
- Competitive Positioning Strategy : Identify market opportunities and competitive dynamics specific to France's digital health ecosystem, helping you position products and services effectively within this high-growth European market.
- Strategic Partnership Opportunities : Discover key stakeholders, pharmaceutical companies, biotech firms, and healthcare institutions in France driving wearable adoption, enabling targeted partnership and collaboration strategies.
Frequently asked questions
What is the current market size of wearables in pharma & biotech in France?
France's wearables in pharma and biotech market is valued at USD 240.7 million in 2026, with strong growth momentum driven by digital health adoption and regulatory support.
What is the projected market size for France's wearables in pharma & biotech by 2031?
France's market is projected to reach USD 672.7 million by 2031, representing nearly a 180% increase from 2026 levels.
What is the CAGR for France's wearables in pharma & biotech market?
France's wearables in pharma and biotech market is growing at a compound annual growth rate of 22.8% from 2026 to 2031.
What are the primary drivers of growth in France's wearables market?
Key drivers include France's advanced healthcare infrastructure, government digital transformation initiatives, increasing adoption of remote patient monitoring, real-world evidence generation, and clinical trial optimization.
Which therapeutic areas are leading wearables adoption in France?
France is seeing significant wearables adoption in cardiology, neurology, and metabolic disorder management, supported by strong pharmaceutical and biotech sector investment.
RESEARCH METHODOLOGY
This study involved five major activities to estimate the current size of the wearables in pharma & biotech market. Exhaustive secondary research was conducted to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to to identify and collect information for the study of the wearables in pharma & biotech market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global wearables in pharma & biotech market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (hospital directors, hospital vice presidents, department heads, and critical care specialists) and supply side (such as C-level and D-level executives, technology experts, product managers, marketing and sales managers, among others) across five major regions: North America, Europe, Asia Pacific, Latin America, the Middle East & Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
The following is a breakdown of the primary respondents:
Note: Tiers of companies are defined based on their total revenues in 2023. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = USD 500 million. Other designations include sales managers, marketing managers, and product managers.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the wearables in pharma & biotech market. These methods were also used extensively to estimate the size of various subsegments in the market.
The research methodology used to estimate the market size includes the following:
Wearables in Pharma & Biotech Market : Top-Down and Bottom-Up Approach
Data Triangulation
After arriving at the overall market size using the market size estimation processes, the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the wearables in pharma & biotech market.
Market Definition
The wearables in pharma & biotech market comprise sensor-based, body-worn, or minimally invasive devices and associated digital platforms used to capture continuous physiological and behavioral data across the drug development and healthcare continuum. This includes products such as smartwatches, fitness bands, smart rings, continuous glucose monitors (CGMs), wearable patches, and wearable injectors, which enable real-time monitoring of parameters like heart rate, glucose levels, activity, and treatment adherence. These technologies are applied across a wide range of therapeutic areas, including cardiovascular diseases, oncology (solid tumors and hematologic malignancies), diabetes, mental health, respiratory, neurological, musculoskeletal, and women’s health conditions. The market spans key applications, such as drug discovery, clinical trials (Phase II–IV), medication adherence, chronic disease monitoring, and personalized digital therapeutics, supporting decentralized trials and real-world evidence generation. End users primarily include pharmaceutical and biotechnology companies, healthcare providers, and research organizations, all leveraging wearable technologies to enable data-driven, patient-centric care and more efficient drug development.
Key Stakeholders
- Wearable device & biosensor manufacturers (smartwatches, CGMs, patches, smart rings, wearable injectors)
- Digital health & software platform providers (mobile apps, cloud platforms, AI analytics)
- Component, sensor, & semiconductor technology providers
- Pharmaceutical companies
- Biotechnology companies
- Contract research organizations (CROs)
- Clinical trial sponsors & site management organizations
- Healthcare providers (hospitals, clinics, remote patient monitoring programs)
- Patients & caregivers
- Payers & insurers
- Regulatory & public health authorities (e.g., US Food and Drug Administration, European Medicines Agency)
- Academic institutions & research organizations
- Data management, interoperability & cloud infrastructure providers
- Cybersecurity & data privacy solution providers
- System integrators & IT service providers
- Venture capital & private equity firms
- Investors & financial institutions
- Consulting, regulatory, & compliance service providers
Report Objectives
- To define, describe, and forecast the wearables in pharma & biotech market based on product, therapeutic area, application, end user, and region
- To provide detailed information regarding the major factors (such as drivers, restraints, opportunities, and challenges) influencing market growth
- To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To strategically analyze the market structure profile of the key players and comprehensively analyze their core competencies
- To forecast the size of the market segments with respect to five regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
- To track and analyze competitive developments such as product launches and enhancements, investments, partnerships, collaborations, acquisitions, expansions, product approvals, and alliances in the market
Customization Options:
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
- Product matrix, which gives a detailed comparison of the product portfolios of each company.
Geographic Analysis
- Further breakdown of the Latin America, Europe, and the Middle East & Africa markets into specific countries
Get the Full Wearables in Pharma & Biotech Market Report
Full forecast, segment splits, and company analysis for all Wearables in Pharma & Biotech Market.
- US Wearables in Pharma & Biotech Market
- Canada Wearables in Pharma & Biotech Market
- Germany Wearables in Pharma & Biotech Market
- UK Wearables in Pharma & Biotech Market
- Italy Wearables in Pharma & Biotech Market
- Spain Wearables in Pharma & Biotech Market
- China Wearables in Pharma & Biotech Market
- Japan Wearables in Pharma & Biotech Market
- India Wearables in Pharma & Biotech Market
- Australia Wearables in Pharma & Biotech Market
- South Korea Wearables in Pharma & Biotech Market
- Brazil Wearables in Pharma & Biotech Market
- Mexico Wearables in Pharma & Biotech Market
- Saudi Arabia Wearables in Pharma & Biotech Market
- UAE Wearables in Pharma & Biotech Market
- South Africa Wearables in Pharma & Biotech Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report